Sweta Kavali, MD
Ophthalmology · Des Peres, MONPI 1669673067
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,619 of the $7,896 with a category attached, or 83.8%. 30 manufacturers reported payments, led by AbbVie at 27.0% of the total.
Across 186 payments — averaging $42.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Alimera Sciences, Inc.$848
- Regeneron Healthcare Solutions, Inc.$577
- Genentech USA, Inc.$563
- Astellas Pharma US Inc$499
- Alcon$458
- plus $3K from 24 others
What the payments were for
- Consulting fees$1,16415%
- Food & beverage$6,61984%
- Education$941%
- Gifts$190%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 46 | $2,130 |
| Alimera Sciences, Inc. | 14 | $848 |
| Regeneron Healthcare Solutions, Inc. | 11 | $577 |
| Genentech USA, Inc. | 28 | $563 |
| Astellas Pharma US Inc | 13 | $499 |
| Alcon | 9 | $458 |
| Regeneron | 4 | $401 |
| ANI Pharmaceuticals, Inc. | 8 | $322 |
| Apellis Pharmaceuticals, Inc. | 4 | $295 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 5 | $284 |
| Bausch & Lomb Americas Inc. | 7 | $236 |
| Novartis | 3 | $222 |
| Biogen | 5 | $138 |
| Eyepoint US, Inc. | 2 | $137 |
| Glaukos Corporation | 1 | $129 |
| Ivantis, Inc | 1 | $117 |
| Sun Pharmaceutical Industries Inc. | 3 | $81 |
| Eyevance Pharmaceuticals LLC | 4 | $63 |
| Kala Pharmaceuticals, Inc. | 3 | $60 |
| Sight Sciences, Inc. | 2 | $50 |
| The Cameron-ehlen Group, Inc. | 1 | $49 |
| Tarsus Pharmaceuticals, Inc. | 1 | $36 |
| Oyster Point Pharma, Inc. | 2 | $33 |
| Amgen(2 entities) | 2 | $32 |
| Johnson & Johnson Surgical Vision, Inc. | 2 | $30 |
| Ocular Therapeutix, Inc. | 1 | $23 |
| Mallinckrodt Hospital Products Inc. | 1 | $22 |
| Aerie Pharmaceuticals, Inc. | 1 | $22 |
| Rxsight Inc | 1 | $20 |
| Carl Zeiss Meditec AG | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OZURDEX$1,289
- Iluvien$496
- enVista MX60 IOL$354
- Syfovre$253
- EYLEA HD$246
- STELLARIS$229
- EYLEA$229
- PURIFIED CORTROPHIN GEL$125
- Izervay$124
- YUTIQ$118
- Hydrus$117
- Precision 1$115
- AcrySof IQ PanOptix$111
How this compares
$7,896 in reported general payments places this provider in the 85th percentile of 286 ophthalmology providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 97 | $5,133 |
| Ketorolac Tromethamine | 25 | $613 |
| Timolol Maleate | 22 | $186 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 12 | $131 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Des Peres
- Joseph GiraDes Peres$174K
- Michael DonahoeDes Peres$5K
- Steven SilversteinKansas City$872K
- Ranjan MalhotraSaint Louis$809K
- Nancy HolekampChesterfield$768K
- Jay PeposeChesterfield$516K
- Gregg BerdySaint Louis$360K
- Joseph TauberKansas City$174K
- Jella AnColumbia$166K
- Shachar TauberSpringfield$150K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.